Device / Technology News

RSS

FDA grants 510(k) clearance to Focus Diagnostics Simplexa Flu A/B & RSV test on 3M Integrated Cycler

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has issued 510(k) clearance to the Focus Diagnostics Simplexa Flu A/B & RSV test on the 3M™ Integrated Cycler. The Simplexa test, developed and manufactured by Quest Diagnostics' Focus Diagnostics business, is intended as an aid in the detection and discrimination of influenza A, influenza B and RSV virus infections.

From Quest Diagnostics 2 Dec 2010

Graphene: A new genome sequencing technique

Genome sequencing will have a profound effect on our understanding of genetic biology and could usher in a day when doctor and patient are able to review individual genome sequences to fully personalise medical treatment.

2 Dec 2010

New radiation-free device to detect breast cancer

A new device may enable breast cancer screening and cancer detection in populations where mammography is not widely available or successful, including women in developing countries, and those under the age of 40.

2 Dec 2010

Philips launches Juno DRF and DigitalDiagnost - ER Wireless X-ray solutions at 96th RSNA

Royal Philips Electronics today introduced the Juno DRF and the DigitalDiagnost - ER Wireless systems, two versatile diagnostic X-ray solutions that represent the next step in patient care. Featured at the 96th annual meeting of the Radiological Society of North America (RSNA) in Chicago, these innovative systems uphold Philips' commitment to integrating technologies in a smart way to help enhance patient outcomes and increase value for healthcare systems.

From Philips Healthcare 2 Dec 2010

Cellectis signs agreement with Harvard Apparatus for electroporation-based instruments

Cellectis, the French genome engineering specialist, and Harvard Apparatus, a division of Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, have announced today that they have signed a license agreement that grants Harvard Apparatus the worldwide exclusive right to manufacture and sell, for research use, the full line of electroporation-based instruments acquired by Cellectis from CytoPulse in September of 2010.

2 Dec 2010

CSL Behring launches next generation HeliTrax System for Apple's devices

CSL Behring announced today the availability of the next generation HeliTrax System as part of a specially designed software platform for Apple's iPhone, iPod touch, or iPad devices. This enhanced system is designed to improve therapy management for people with hemophilia A who use CSL Behring's recombinant factor VIII (rFVIII).

2 Dec 2010

GE Healthcare launches eHealth Image Exchange software solution

GE Healthcare today announced its eHealth Image Exchange software solution: a flexible, standards-based platform for sharing images and integrating workflows across a healthcare community.

2 Dec 2010

Collegium completes spin-out of Onset Therapeutics

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, announced today that it has completed the spin-out of Onset Therapeutics, LLC, its wholly owned subsidiary focused on the Dermatology market.

2 Dec 2010

Mindray launches V Series patient monitoring system

Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, today introduced the Mindray V Series patient monitoring system, an all new scalable platform that focuses on the clarity and continuity of data at a single point of care. The V Series solution is the result of research focused on identifying the unique challenges of critical care and other high acuity environments.

From Mindray 2 Dec 2010

New cell-based assay for reliable testing of HIV inhibitors

EASY-HIT is a new cell-based assay system for simple and reliable testing of HIV inhibitors. This system was developed under the leadership of Professor Ruth Brack-Werner at the Institute of Virology.

2 Dec 2010

MiMedx awarded QTDP grant for CollaFix drug delivery device

MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it has been awarded a Qualifying Therapeutic Discovery Project grant (QTDP) from the U.S. Government. The grant, in the amount of $244,479, has been made to defer some of the Company's research expenditures related to the development of its novel and patented technology, CollaFix™, as a drug delivery device.

2 Dec 2010

Dec. 1 news from RSNA 2010

The risk of developing radiation-induced cancer from computed tomography (CT) may be lower than previously thought, according to a Stanford University study. Using more than 10 million Medicare claims from 1998 through 2005, the researchers analyzed the distribution of CT scans, determined the ionizing radiation exposure associated with the exams and estimated the associated cancer risk in a population of older adults.

1 Dec 2010

DecisionView releases StudyOptimizer 4.2 patient enrollment planning, tracking and forecasting solution

DecisionView Inc., a leading provider of software solutions to optimize clinical trial enrollment for life sciences companies, today announced the release of DecisionView StudyOptimizer 4.2, the latest version of the company's flagship solution for patient enrollment planning, tracking and forecasting. By providing better insight into historical enrollment performance and future cost projections, StudyOptimizer 4.2 significantly improves the ability of global pharmaceutical customers to optimize enrollment plans and deliver clinical trials on time and on budget.

1 Dec 2010

Toshiba introduces women's imaging configuration for Aplio XG at RSNA 2010

Many healthcare providers use ultrasound as a first-line diagnostic tool in detecting and monitoring women's health conditions. To help meet the needs of healthcare providers administering women's imaging, Toshiba has introduced a women's imaging configuration for the Aplio™ XG at this year's Radiological Society of North America (RSNA) annual meeting in Chicago, Nov. 28 - Dec. 3, 2010.

1 Dec 2010

Toshiba showcases new Vantage Titan 3T open bore MR at RSNA 2010

For many patients, claustrophobia and acoustic noise can make MR imaging uncomfortable. Understanding this challenge, Toshiba America Medical Systems, Inc. developed a 3T MR system designed to improve patient compliance and comfort while offering advanced radiology capabilities for healthcare facilities.

1 Dec 2010

IMIA, GHIP announce strategic alliance to strengthen health information and communication systems

The International Medical Informatics Association (IMIA) and the Global Health Informatics Partnership (GHIP) have announced a strategic alliance to strengthen health information and communication (HICT) systems, create learning modules appropriate for a wide variety of workers in public health and clinical roles, and facilitate infrastructures and policies that support sustained investment in HICT and informatics at the global level.

1 Dec 2010

Penicillamine challenge ineffective for detecting Wilson's disease in asymptomatic children

An Italian research team confirmed that the scoring system for Wilson's disease (WD) provides good diagnostic accuracy with 93% positive and 92% negative predictive values, respectively in children with mild liver disease. In asymptomatic children, a urinary copper excretion above 40 μg/24 hours was suggestive of WD, however the penicillamine challenge test (PCT) did not provide an accurate diagnosis in this patient subset.

1 Dec 2010

OraSure supports rapid HIV testing initiatives to recognize World AIDS Day

OraSure Technologies, Inc., the market leader in oral fluid diagnostics, today announced its support of more than 150 rapid HIV testing initiatives taking place in more than 25 states in the U.S. and numerous countries globally, in recognition of World AIDS Day, commemorated annually on December 1st.

1 Dec 2010

New experimental device could offer effective treatment option for people with swallowing disorders

In what might be one of the world's first medicinal body piercings, UC Davis Health System surgeons announced today that they have successfully implanted an experimental device in the throat of a man that will enable him to manually control his ability to swallow.

1 Dec 2010

SILADENT and Innodema appointed as SensAble Authorized Production Centers

SensAble Technologies Inc., a leading provider of dental restoration design and fabrication solutions, 3D modeling software and haptic devices, announced that it has further expanded its network of European partners in service to the growing dental lab business in Europe. The company today announced partnerships with SILADENT Dr. Böhme & Schöps GmbH, Goslar, German and Innodema, an alliance of dental lab fabrication experts based in Belgium, both of whom become SensAble Authorized Production Centers (SAPCs).

1 Dec 2010